226 related articles for article (PubMed ID: 31271757)
21. Beyond the aspirational: creating the future of health care in Australia.
Braithwaite J; Fisher G
Intern Med J; 2024 Feb; 54(2):342-347. PubMed ID: 37926972
[TBL] [Abstract][Full Text] [Related]
22. Translational Genomics in Low- and Middle-Income Countries: Opportunities and Challenges.
Tekola-Ayele F; Rotimi CN
Public Health Genomics; 2015; 18(4):242-7. PubMed ID: 26138992
[TBL] [Abstract][Full Text] [Related]
23. Personalized Medicine: What's in it for Rare Diseases?
Schee Genannt Halfmann S; Mählmann L; Leyens L; Reumann M; Brand A
Adv Exp Med Biol; 2017; 1031():387-404. PubMed ID: 29214584
[TBL] [Abstract][Full Text] [Related]
24. What Precision Medicine Can Learn from Rare Genetic Disease Research and Translation.
Tabor HK; Goldenberg A
AMA J Ethics; 2018 Sep; 20(9):E834-840. PubMed ID: 30242814
[TBL] [Abstract][Full Text] [Related]
25. Advancing Understanding of Inequities in Rare Disease Genomics.
Serrano JG; O'Leary M; VanNoy GE; Mangilog BE; Holm IA; Fraiman YS; Rehm HL; O'Donnell-Luria A; Wojcik MH
Clin Ther; 2023 Aug; 45(8):745-753. PubMed ID: 37517917
[TBL] [Abstract][Full Text] [Related]
26. Healthcare System Priorities for Successful Integration of Genomics: An Australian Focus.
Burns BL; Bilkey GA; Coles EP; Bowman FL; Beilby JP; Pachter NS; Baynam G; Dawkins HJS; Weeramanthri TS; Nowak KJ
Front Public Health; 2019; 7():41. PubMed ID: 30915324
[TBL] [Abstract][Full Text] [Related]
27. Integration of nurse practitioners using a change management framework: the way forward.
Lowe G; Plummer V; Boyd L
Aust Health Rev; 2017 Oct; 41(5):553-560. PubMed ID: 27712615
[TBL] [Abstract][Full Text] [Related]
28. Genomic Medicine in Primary Care.
Hajek C
S D Med; 2017 Spec; Spec No():62-65. PubMed ID: 28817866
[TBL] [Abstract][Full Text] [Related]
29. Healthcare System-Funded Preventive Genomic Screening: Challenges for Australia and Other Single-Payer Systems.
Lacaze P; Tiller J; Winship I
Public Health Genomics; 2019; 22(3-4):140-144. PubMed ID: 31550728
[TBL] [Abstract][Full Text] [Related]
30. Translating Aboriginal genomics - four letters Closing the Gap.
Baynam GS; Pearson G; Blackwell J
Med J Aust; 2016 Oct; 205(8):379. PubMed ID: 27736627
[No Abstract] [Full Text] [Related]
31. Unlocking the genomic landscape: Results of the Beyond 1 Million Genomes (B1MG) pilot in Belgium towards Genomic Data Infrastructure (GDI).
Schmitt T; Poirel HA; Cauët E; Delnord M; Van den Bulcke M
Health Policy; 2024 May; 143():105060. PubMed ID: 38598968
[TBL] [Abstract][Full Text] [Related]
32. Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations.
Dearfield KL; Gollapudi BB; Bemis JC; Benz RD; Douglas GR; Elespuru RK; Johnson GE; Kirkland DJ; LeBaron MJ; Li AP; Marchetti F; Pottenger LH; Rorije E; Tanir JY; Thybaud V; van Benthem J; Yauk CL; Zeiger E; Luijten M
Environ Mol Mutagen; 2017 Jun; 58(5):264-283. PubMed ID: 27650663
[TBL] [Abstract][Full Text] [Related]
33. Rare inherited skin diseases and the Genomics England 100 000 Genome Project.
McGrath JA
Br J Dermatol; 2016 Feb; 174(2):257-8. PubMed ID: 26871914
[No Abstract] [Full Text] [Related]
34. Indigenous Genetics and Rare Diseases: Harmony, Diversity and Equity.
Baynam G; Molster C; Bauskis A; Kowal E; Savarirayan R; Kelaher M; Easteal S; Massey L; Garvey G; Goldblatt J; Pachter N; Weeramanthri TS; Dawkins HJS
Adv Exp Med Biol; 2017; 1031():511-520. PubMed ID: 29214589
[TBL] [Abstract][Full Text] [Related]
35. RD-Connect, NeurOmics and EURenOmics: collaborative European initiative for rare diseases.
Lochmüller H; Badowska DM; Thompson R; Knoers NV; Aartsma-Rus A; Gut I; Wood L; Harmuth T; Durudas A; Graessner H; Schaefer F; Riess O; ; ;
Eur J Hum Genet; 2018 Jun; 26(6):778-785. PubMed ID: 29487416
[TBL] [Abstract][Full Text] [Related]
36. Readiness of clinical genetic healthcare professionals to provide genomic medicine: An Australian census.
Nisselle A; Macciocca I; McKenzie F; Vuong H; Dunlop K; McClaren B; Metcalfe S; Gaff C;
J Genet Couns; 2019 Apr; 28(2):367-377. PubMed ID: 30779404
[TBL] [Abstract][Full Text] [Related]
37. Integration of genomics and metabolomics for prioritization of rare disease variants: a 2018 literature review.
Graham E; Lee J; Price M; Tarailo-Graovac M; Matthews A; Engelke U; Tang J; Kluijtmans LAJ; Wevers RA; Wasserman WW; van Karnebeek CDM; Mostafavi S
J Inherit Metab Dis; 2018 May; 41(3):435-445. PubMed ID: 29721916
[TBL] [Abstract][Full Text] [Related]
38. Initiating an undiagnosed diseases program in the Western Australian public health system.
Baynam G; Broley S; Bauskis A; Pachter N; McKenzie F; Townshend S; Slee J; Kiraly-Borri C; Vasudevan A; Hawkins A; Schofield L; Helmholz P; Palmer R; Kung S; Walker CE; Molster C; Lewis B; Mina K; Beilby J; Pathak G; Poulton C; Groza T; Zankl A; Roscioli T; Dinger ME; Mattick JS; Gahl W; Groft S; Tifft C; Taruscio D; Lasko P; Kosaki K; Wilhelm H; Melegh B; Carapetis J; Jana S; Chaney G; Johns A; Owen PW; Daly F; Weeramanthri T; Dawkins H; Goldblatt J
Orphanet J Rare Dis; 2017 May; 12(1):83. PubMed ID: 28468665
[TBL] [Abstract][Full Text] [Related]
39. Leveraging Evidence-Based Public Policy and Advocacy to Advance Newborn Screening in California.
Bronstein MG; Pan RJ; Dant M; Lubin B
Pediatrics; 2019 Feb; 143(2):. PubMed ID: 30606745
[TBL] [Abstract][Full Text] [Related]
40. Integrating precision cancer medicine into healthcare-policy, practice, and research challenges.
Bertier G; Carrot-Zhang J; Ragoussis V; Joly Y
Genome Med; 2016 Oct; 8(1):108. PubMed ID: 27776531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
